Ghent University Academic Bibliography

Advanced

Total mesorectal excision in the treatment of rectal cancer: a review

Wim Ceelen UGent and Piet Pattyn UGent (2000) ACTA CHIRURGICA BELGICA. 100(3). p.94-99
abstract
Despite the improvements in preoperative staging, surgical technique and adjuvant therapy, local recurrence remains a significant problem in rectal cancer surgery. Several patient- and tumour-related risk factors for the development of local recurrence have been identified and are being addressed by regimens of pre- or postoperative adjuvant therapy. Total mesorectal excision (TME) recently has been shown to result in a low recurrence rate even without the use of adjuvant therapy. Nevertheless, conclusive evidence in the form of a prospective randomized trial is to date not available. This paper describes the technique of TME and reviews the clinical and pathological data supporting its use in rectal cancer surgery.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (review)
publication status
published
subject
keyword
mesorectum, rectal cancer, surgery, therapy, LOCAL RECURRENCE, ANTERIOR RESECTION, COLORECTAL-CANCER, SURGICAL-TREATMENT, PELVIC RECURRENCE, LOW ANASTOMOSIS, SURVIVAL RATES, TUMOR SPREAD, CARCINOMA, SURGERY
journal title
ACTA CHIRURGICA BELGICA
Acta Chir. Belg.
volume
100
issue
3
pages
94 - 99
Web of Science type
Review
Web of Science id
000088458600004
ISSN
0001-5458
language
English
UGent publication?
yes
classification
A1
id
172133
handle
http://hdl.handle.net/1854/LU-172133
date created
2004-01-14 13:40:00
date last changed
2017-03-08 15:40:28
@article{172133,
  abstract     = {Despite the improvements in preoperative staging, surgical technique and adjuvant therapy, local recurrence remains a significant problem in rectal cancer surgery.
Several patient- and tumour-related risk factors for the development of local recurrence have been identified and are being addressed by regimens of pre- or postoperative adjuvant therapy.
Total mesorectal excision (TME) recently has been shown to result in a low recurrence rate even without the use of adjuvant therapy. Nevertheless, conclusive evidence in the form of a prospective randomized trial is to date not available.
This paper describes the technique of TME and reviews the clinical and pathological data supporting its use in rectal cancer surgery.},
  author       = {Ceelen, Wim and Pattyn, Piet},
  issn         = {0001-5458},
  journal      = {ACTA CHIRURGICA BELGICA},
  keyword      = {mesorectum,rectal cancer,surgery,therapy,LOCAL RECURRENCE,ANTERIOR RESECTION,COLORECTAL-CANCER,SURGICAL-TREATMENT,PELVIC RECURRENCE,LOW ANASTOMOSIS,SURVIVAL RATES,TUMOR SPREAD,CARCINOMA,SURGERY},
  language     = {eng},
  number       = {3},
  pages        = {94--99},
  title        = {Total mesorectal excision in the treatment of rectal cancer: a review},
  volume       = {100},
  year         = {2000},
}

Chicago
Ceelen, Wim, and Piet Pattyn. 2000. “Total Mesorectal Excision in the Treatment of Rectal Cancer: a Review.” Acta Chirurgica Belgica 100 (3): 94–99.
APA
Ceelen, Wim, & Pattyn, P. (2000). Total mesorectal excision in the treatment of rectal cancer: a review. ACTA CHIRURGICA BELGICA, 100(3), 94–99.
Vancouver
1.
Ceelen W, Pattyn P. Total mesorectal excision in the treatment of rectal cancer: a review. ACTA CHIRURGICA BELGICA. 2000;100(3):94–9.
MLA
Ceelen, Wim, and Piet Pattyn. “Total Mesorectal Excision in the Treatment of Rectal Cancer: a Review.” ACTA CHIRURGICA BELGICA 100.3 (2000): 94–99. Print.